Edwards Lifesciences Corp... (EW)
NYSE: EW
· Real-Time Price · USD
75.27
0.60 (0.81%)
At close: Sep 25, 2025, 3:59 PM
75.27
0.00%
After-hours: Sep 25, 2025, 05:01 PM EDT
0.81% (1D)
| Bid | 74 |
| Market Cap | 44.19B |
| Revenue (ttm) | 5.69B |
| Net Income (ttm) | 4.14B |
| EPS (ttm) | 2.39 |
| PE Ratio (ttm) | 31.49 |
| Forward PE | 26.73 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 75.99 |
| Volume | 5,039,471 |
| Avg. Volume (20D) | 4,353,547 |
| Open | 74.50 |
| Previous Close | 74.67 |
| Day's Range | 73.70 - 75.53 |
| 52-Week Range | 64.01 - 83.00 |
| Beta | 1.07 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for EW stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEdwards Lifesciences Corporation is scheduled to release its earnings on
Oct 23, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+5.54%
Edwards Lifesciences shares are trading higher fol...
Unlock content with
Pro Subscription
2 months ago
-1.44%
Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · businesswire.com
Edwards Lifesciences Announces $500 Million Accelerated Share RepurchaseIRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards' common st...
1 month ago · seekingalpha.com
Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti...